Appointment, promotions announced for medical school faculty members
Clarence Braddock III
Jonathan Katz
BY JOYCE THOMAS
Clarence H. Braddock III, MD, MPH, joined the faculty officially July 1 with his appointment as associate professor of medicine. He has been an acting associate professor and director of the “Practice of Medicine” course since October.
His primary scholarly focus has been on doctor-patient communication, including the use of quantitative methods to analyze videotaped interactions between physicians and patients.
He is co-principal investigator on “Informed Decision Making Between Surgeons and Older Patients” funded by the National Institute on Aging and projects examining informed decision making for prostate cancer screening and colorectal cancer screening. He has authored papers in JAMA, Journal of Clinical Ethics and Journal of General Internal Medicine.
Braddock, a Stanford University alumnus, received his medical degree in 1981 from the University of Chicago Pritzker School of Medicine. His postdoctoral training included an internal medicine residency in the U.S. Navy, followed by a three-year assignment overseas. He was a Robert Wood Johnson Minority Faculty Development fellow from 1997 to 2001. Before relocating to Stanford he served on the faculty at the University of Washington, where he developed an integrated bioethics curriculum for the medical school.
Pehr A.B. Harbury, PhD, was promoted to associate professor of biochemistry, with tenure.
Harbury was among 100 Young Innovators honored by MIT’s Technology Review magazine. He received a 2004 Schering-Plough Young Investigator Award from the American Society of Biochemistry and Molecular Biology. He received a Searle Scholar Young Investigator Award and a Burroughs-Wellcome Young Investigator Award.
His lab engineers proteins and small-molecule drugs at atomic resolution through a combination of structural calculations and combinatorial library synthesis. His research includes a project that aims to predict amino acid sequences that will fold into a specified shape using computer modeling, a second project that focuses on determining the conformations of large proteins in complex solutions and a third that attempts the rapid creation of drug-like ligands for designated protein targets.
He received his BA and MA in biochemistry and his PhD in biological chemistry from Harvard. His PhD research was conducted at MIT’s Whitehead Institute and his postdoctoral work was done at UC-Berkeley. He joined Stanford in 1997.
Jonathan Katz, MD, was promoted to associate professor of neurology and neurological sciences. He is a clinical neurologist, board certified in psychiatry and neurology with added qualification in clinical neurophysiology.
He serves at the Stanford neurology clinic and as full-time clinical neurologist at the Veterans Affairs Palo Alto medical center.
His scholarly work focuses on the evaluation and treatment of neuromuscular disorders. His projects include a group study on the identification of genetic factors associated with a novel adult-onset type of muscular dystrophy in women, a study of causation in statin-associated myopathy and case studies of clinical trials in hereditary myopathy and neuropathy.
Katz earned his MD at Tulane University in 1988. He completed an internship at Brown, a neurology residency at the University of Washington and a fellowship in neuromuscular disease at the University of Texas-Southwestern. He was appointed to the Stanford faculty in 1997.
Share This Story